Capricor Therapeutics (CAPR) Total Debt (2010 - 2024)
Capricor Therapeutics (CAPR) recorded quarterly Total Debt of $3.4 million in Q3 2024, little changed quarter-over-quarter from $3.4 million in Q2 2024, and little changed on a YoY basis from $3.4 million in Q4 2023.
Capricor Therapeutics (CAPR) Total Debt (2010 - 2024) Analysis & Trends
Capricor Therapeutics' Total Debt history runs 15 years deep, the most recent figure standing at $3.4 million for Q3 2024.
- In Q3 2024, Total Debt changed 0.0% year-over-year to $3.4 million; the TTM figure through Sep 2024 stood at $3.4 million (changed 0.0% YoY), while the FY2023 annual figure was $3.4 million, down 2.57% from the prior year.
- Total Debt was $3.4 million for Q3 2024 at Capricor Therapeutics, roughly flat from $3.4 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $4.0 million in Q4 2021 to a low of $178233.0 in Q2 2020.
- Historically, Total Debt has averaged $3.3 million across 5 years, with a median of $3.4 million in 2020.
- The sharpest annual moves came in 2020 and 2021: Total Debt plunged 94.72% in 2020, then surged 1794.3% in 2021.
- A 5-year view of Total Debt shows it stood at $3.4 million in 2020, then advanced by 17.75% to $4.0 million in 2021, then dropped by 12.83% to $3.5 million in 2022, then slipped by 2.57% to $3.4 million in 2023, then changed by 0.0% to $3.4 million in 2024.
- The last three Total Debt figures came in at $3.4 million (Q3 2024), $3.4 million (Q2 2024), and $3.4 million (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 3.38 Mn |
| Jun 30, 2024 | 3.38 Mn |
| Mar 31, 2024 | 3.38 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 3.39 Mn |
| Mar 31, 2023 | 3.39 Mn |
| Dec 31, 2022 | 3.47 Mn |
| Sep 30, 2022 | 3.46 Mn |
| Jun 30, 2022 | 3.47 Mn |
| Mar 31, 2022 | 3.95 Mn |
| Dec 31, 2021 | 3.98 Mn |
| Jun 30, 2021 | 3.38 Mn |
| Mar 31, 2021 | 3.38 Mn |
| Dec 31, 2020 | 3.38 Mn |
| Sep 30, 2020 | 3.38 Mn |
| Jun 30, 2020 | 178,233.00 |
| Mar 31, 2020 | 3.38 Mn |
| Dec 31, 2019 | 3.38 Mn |
| Sep 30, 2019 | 3.38 Mn |